Alnylam Pharmaceuticals (ALNY) Times Interest Earned (2011 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Times Interest Earned of $3.88 for Q1 2026, down 99.71% on a QoQ basis from $1317.2 in Q4 2025, and up 1378.45% year-over-year from $0.26 in Q1 2025.
Alnylam Pharmaceuticals (ALNY) Times Interest Earned (2011 - 2026) Analysis & Trends
Alnylam Pharmaceuticals' Times Interest Earned history runs 14 years deep, the most recent figure standing at $3.88 for Q1 2026.
- Quarterly Times Interest Earned rose 1378.45% year-over-year to $3.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.88 (up 1044.57% YoY) and the FY2025 annual result came in at $1.99, up 3230.44% from the prior year.
- Times Interest Earned was $3.88 for Q1 2026 at Alnylam Pharmaceuticals, down from $1317.2 in the prior quarter.
- Across five years, Times Interest Earned topped out at $1317.2 in Q4 2025 and bottomed at -$7.65 in Q2 2023.
- A 5-year average of $76.88 and a median of -$1.21 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned plunged 154.15% — and 2025, when it soared 108584.26%.
- Alnylam Pharmaceuticals' Times Interest Earned stood at $2.27 in 2022, then plunged by 154.15% to -$1.23 in 2023, then rose by 1.38% to -$1.21 in 2024, then soared by 108584.26% to $1317.2 in 2025, then sank by 99.71% to $3.88 in 2026.
- Business Quant data shows ALNY's Times Interest Earned at $3.88 in Q1 2026, $1317.2 in Q4 2025, and $8.29 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 3.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.88 |
| Dec 31, 2025 | 1,317.18 |
| Sep 30, 2025 | 8.29 |
| Jun 30, 2025 | -0.40 |
| Mar 31, 2025 | 0.26 |
| Dec 31, 2024 | -1.21 |
| Sep 30, 2024 | -2.24 |
| Jun 30, 2024 | 1.46 |
| Mar 31, 2024 | -1.23 |
| Dec 31, 2023 | -1.23 |
| Sep 30, 2023 | 6.92 |
| Jun 30, 2023 | -7.65 |
| Mar 31, 2023 | -5.17 |
| Dec 31, 2022 | 2.27 |
| Sep 30, 2022 | -6.28 |
| Jun 30, 2022 | -4.50 |
| Mar 31, 2022 | -3.46 |
| Dec 31, 2021 | -5.28 |
| Sep 30, 2021 | -4.51 |
| Jun 30, 2021 | -4.37 |